Diseases, Conditions, Syndromes

More die as mysterious illness spreads to Liberia capital

More people have died following the outbreak of a mysterious illness that began in southeastern Liberia but has spread to the capital, with 12 unexplained deaths so far, health authorities told AFP Tuesday.

Diseases, Conditions, Syndromes

Early blood signatures of vaccine immunogenicity

Within seven days of vaccination, a blood test early after vaccination can predict whether vaccines based on living, modified viruses have had the desired effect. This is one of the results of a new study from a large European ...

Diseases, Conditions, Syndromes

CDC/WHO Ebola guidelines could put sewer workers at risk

Research from Drexel University and the University of Pittsburgh suggests that guidelines for safe disposal of liquid waste from patients being treated for the Ebola virus might not go far enough to protect water treatment ...

Diseases, Conditions, Syndromes

New model maps likelihood of Ebola spillovers

Ecologists at the University of Georgia have developed a model that maps the likelihood of Ebola virus "spillovers"-when the virus jumps from its long-term host to humans or animals such as great apes-across Africa on a month-by-month ...

Medical research

Findings offer new ideas about vaccine development

Vaccine development is largely trial and error—which results in years of pricey development and just a 6 percent success rate—but a University of Michigan researcher believes he's found a way to potentially improve those ...

Diseases, Conditions, Syndromes

Interferon drug shows promise in treating Ebola

Toronto)—A pilot study of a class of drugs used to treat hepatitis and some forms of multiple sclerosis has been shown for the first time to ease symptoms of Ebola patients, while also increasing their survival.

page 38 from 40